GGHSX Mutual Fund

NAV$42.30
Showing 10 of 81 holdings(as of Mar 31, 2026)Top 10 Weight: 42.62%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company9.07%---Health CarePharmaceuticals
2JNJJOHNSON AND JOHNSON5.81%---Health CarePharmaceuticals
3AZN:LNAstrazeneca Plc Adr4.34%--ProProPro
4GILDGilead Sciences Inc4.10%--ProProPro
5ABBVAbbvie Inc Health Care3.67%--ProProPro
6CORCencora Inc3.65%--ProProPro
7MCKMckesson Corp.13.59%--ProProPro
8ARGXArgenx NV ADR3.37%--ProProPro
9TPFXXInvesco Treasury Portfolio2.75%--ProProPro
10MRKMerck & Co. Inc.2.27%--ProProPro
See the other 71 holdings of GGHSX
Every position with sector, industry and share changes, as reported Mar 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesImmunologyOncologyAsset ManagementInvestment TechnologyMarket InfrastructureGlobal BankingInterest RatesSupply ChainLife Sciences ToolsBiotechnology ToolsSemiconductorsAging Population

GGHSX Mutual Fund Top Holdings

GGHSX holdings top 10 positions. The top 10 holdings account for 42.6% of the fund, led by Eli Lilly And Company at 9.1%, JOHNSON AND JOHNSON at 5.8%, Astrazeneca Plc Adr at 4.3%.

GGHSX portfolio concentration is moderate, with the top 10 representing 42.6% of total assets. The largest sector exposure is Health Care at 82.3%.

GGHSX sector allocation provides a detailed breakdown. GGHSX overlap tool shows how holdings compare to other funds in your portfolio.